Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin

15 May 2023

Abstract excerpt

The pandemic of COVID-19 has highlighted the intricate relationship between gut microbiome and overall health. Recent studies have shown that the Firmicutes/Bacteroidetes ratio in the gut microbiome may be linked to various diseases including COVID-19 and type 2 diabetes (T2D). Understanding the link between gut microbiome and these diseases is essential for developing strategies for prevention and treatment. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to COVID-19 Clinical Research Studies
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37196542
DOI: 10.1016/j.biopha.2023.114892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metforminPMID 37196542Read ↗

Firmicutes/Bacteroidetes Ratio in the Gut Microbiota and IL-1β, IL-6, IL-8, TLR2, TLR4, TLR5 Gene Expressions in Type 2 DiabetesSemantic proximity Read ↗

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic TreatmentSemantic proximity Read ↗

Gut Microbiome-Based Diagnostic Model to Predict Diabetes MellitusSemantic proximity Read ↗

Associations between Phascolarctobacterium/ Phascolarctobacterium faecium and disorders of glucose and lipid metabolism in type 2 diabetes mellitus - a population cohort studySemantic proximity Read ↗

Association of Firmicutes/Bacteroidetes Ratio with Body Mass Index in Korean Type 2 Diabetes Mellitus PatientsSemantic proximity Read ↗

The Influence of Gut Microbial Species on Diabetes MellitusSemantic proximity Read ↗

Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian CohortSemantic proximity Read ↗

Progressive shifts in the gut microbiome reflect prediabetes and diabetes development in a treatment-naive Mexican cohortSemantic proximity Read ↗

Gut microbiota diversity and C-Reactive Protein are predictors of disease severity in COVID-19 patientsSemantic proximity Read ↗

Gut microbiota characteristics and its biological function analysis in patients with tuberculosis and diabetes mellitus co-morbiditySemantic proximity Read ↗

A Metagenome-Wide Association Study of the Gut Microbiome and Metabolic SyndromeSemantic proximity Read ↗

Bioinformatics analysis of the diversity of gut microbiota and different microbiota on insulin resistance in diabetes mellitus patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.